Patents by Inventor Michael Mosteller

Michael Mosteller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11358341
    Abstract: A support assembly includes a part and a tension support rod. The part is additively manufactured on a base plate and includes a series of stacked layers of material fused together. The tension support rod is attached to the base plate at a first attachment location and is attached to the part at a second attachment location. At least one of the first attachment location or the second attachment location comprises a pivot joint to enable movement of the tension support rod at the pivot joint.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: June 14, 2022
    Assignee: THE BOEING COMPANY
    Inventor: Michael Mosteller Woodworth
  • Publication number: 20210008807
    Abstract: A support assembly includes a part and a tension support rod. The part is additively manufactured on a base plate and includes a series of stacked layers of material fused together. The tension support rod is attached to the base plate at a first attachment location and is attached to the part at a second attachment location. At least one of the first attachment location or the second attachment location comprises a pivot joint to enable movement of the tension support rod at the pivot joint.
    Type: Application
    Filed: July 12, 2019
    Publication date: January 14, 2021
    Applicant: THE BOEING COMPANY
    Inventor: Michael Mosteller Woodworth
  • Patent number: 7858319
    Abstract: Methods of assessing the risk of clinical signs of hypersensitivity reaction to nucleoside antiviral compounds, including abacavir, are described. The methods include genotyping subjects for polymorphisms in the TNF? gene, the class 1 HLA genes, or a combination of both the TNF? and HLA genes.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: December 28, 2010
    Assignee: SmithKline Beecham Corporation
    Inventors: Seth Hetherington, Arlene R Hughes, Eric H Lai, Michael Mosteller, Jr., Denise D Shortino
  • Publication number: 20090306099
    Abstract: Methods of assessing the risk of clinical signs of hypersensitivity reaction to nucleoside antiviral compounds, including abacavir, are described. The methods include genotyping subjects for polymorphisms in the TNF? gene, the class 1 HLA genes, or a combination of both the TNF? and HLA genes.
    Type: Application
    Filed: April 22, 2009
    Publication date: December 10, 2009
    Inventors: Seth HETHERINGTON, Arlene R. HUGHES, Eric H. LAI, Michael MOSTELLER, JR., Denise D. SHORTINO
  • Patent number: 7550261
    Abstract: Methods of assessing the risk of clinical signs of hypersensitivity reaction to nucleoside antiviral compounds, including abacavir, are described. The methods include genotyping subjects for polymorphisms in the TNF? gene, the class 1 HLA genes, or a combination of both the TNF? and HLA genes.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: June 23, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Seth Hetherington, Arlene R Hughes, Eric H Lai, Michael Mosteller, Jr., Denise D Shortino
  • Publication number: 20070148641
    Abstract: Methods of assessing the risk of clinical signs of hypersensitivity reaction to nucleoside antiviral compounds, including abacavir, are described. The methods include genotyping subjects for polymorphisms in the TNF? gene, the class 1 HLA genes, or a combination of both the TNF? and HLA genes.
    Type: Application
    Filed: August 7, 2002
    Publication date: June 28, 2007
    Inventors: Seth Hetherington, Arlene Hughes, Eric Lai, Michael Mosteller, Denise Shortino
  • Publication number: 20030124566
    Abstract: Correlations between polymorphisms in the 5-hydroxytryptamine transporter gene are a subject's phenotypic response to treatment with 5-hydroxytryptamine ligands are described.
    Type: Application
    Filed: August 6, 2002
    Publication date: July 3, 2003
    Inventors: Ning Steven Kong, Penelope K. Manasco, Michael Mosteller Jr
  • Publication number: 20030096274
    Abstract: Methods of assessing the risk of clinical signs of hypersensitivity reaction to nucleoside antiviral compounds, including abacavir, are described. The methods include genotyping subjects for polymorphisms in the TNF&agr; gene, the class 1 HLA genes, or a combination of both the TNF&agr; and HLA genes.
    Type: Application
    Filed: August 7, 2002
    Publication date: May 22, 2003
    Inventors: Seth Hetherington, Arlene R. Hughes, Eric H. Lai, Michael Mosteller, Denise D. Shortino